Page last updated: 2024-09-03

pentarane b and Breast Neoplasms

pentarane b has been researched along with Breast Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fedosov, AV; Fedotcheva, TA; Kamernitskii, AV; Levina, IS; Semeikin, AV; Shimanovskii, NL	1

Other Studies

1 other study(ies) available for pentarane b and Breast Neoplasms

Article	Year
6alpha-Methyl-16alpha,17alpha-cyclohexane progesterone and progesterone inhibit growth of doxorubicin-sensitive MCF-7 and HeLa tumor cells. Bulletin of experimental biology and medicine, 2002, Volume: 134, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Division; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Female; HeLa Cells; Humans; Progesterone; Time Factors; Tumor Cells, Cultured	2002

Article

Year

6alpha-Methyl-16alpha,17alpha-cyclohexane progesterone and progesterone inhibit growth of doxorubicin-sensitive MCF-7 and HeLa tumor cells.

Bulletin of experimental biology and medicine, 2002, Volume: 134, Issue:4

Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Division; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Female; HeLa Cells; Humans; Progesterone; Time Factors; Tumor Cells, Cultured

2002